Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure

European Heart Journal

Volumn 26, Issue 17, 2005, Pages 1752-1758

  Iaccarino, Guido ^a   Barbato, Emanuele ^a,d   Cipolletta, Ersilia ^a   De Amicis, Vincenzo ^a   Margulies, Kenneth B ^b,e   Leosco, Dario ^a   Trimarco, Bruno ^a   Koch, Walter J ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Dipartimento Scienze Cardiologiche   (Italy)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adrenergic; Beta; Heart failure; Lymphocytes; Prognosis; Receptors; Signal transduction

Indexed keywords

CATECHOLAMINE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR KINASE 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE; HEART MUSCLE BIOPSY; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONITORING; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS;

AGED; BETA-ADRENERGIC RECEPTOR KINASE; BIOLOGICAL MARKERS; CYCLIC AMP; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; STROKE VOLUME;

EID: 24044543283     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi429     Document Type: Article

References (43)

1. Brodde OE. Beta-adrenergic receptors in failing human myocardium. Basic Res Cardiol 1996;91:35-40.
2. Stiles GL, Lefkowitz RJ. Cardiac adrenergic receptors. Annu Rev Med 1984;35:149-164.
3. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002;415:206-212.
4. Lefkowitz RJ. G protein-coupled receptor kinases. Cell 1993;74:409-412.
5. Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002;3:639-650.
6. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 1995;268:1350-1353.
7. Rockman HA, Choi DJ, Akhter SA, Jaber M, Giros B, Lefkowitz RJ, Caron MG, Koch WJ. Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice. J Biol Chem 1998;273:18180-18184.
8. Ungerer M, Bohm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor kinase and beta 1- adrenergic receptors in the failing human heart (see comments). Circulation 1993;87:454-463.
9. Ungerer M, Parruti G, Bohm M, Puzicha M, DeBlasi A, Erdmann E, Lohse MJ. Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res 1994;74:206-213.
10. Maurice JP, Shah AS, Kypson AP, Hata JA, White DC, Glower DD, Koch WJ. Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol 1999;276:H1853-1860.
11. Anderson KM, Eckhart AD, Willette RN, Koch WJ. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 1999;33:402-407.
12. Ping P, Anzai T, Gao M, Hammond HK. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol 1997;273:H707-717.
13. Harris CA, Chuang TT, Scorer CA. Expression of GRK2 is increased in the left ventricles of cardiomyopathic hamsters. Basic Res Cardiol 2001;96:364-368.
14. Rockman HA, Chien KR, Choi DJ, Iaccarino G, Hunter JJ, Ross J Jr, Lefkowitz RJ, Koch WJ. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. Proc Natl Acad Sci USA 1998;95:7000-7005.
15. White DC, Hata JA, Shah AS, Glower DD, Lefkowitz RJ, Koch WJ. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci USA 2000;97:5428-5433.
16. Brodde OE, Kretsch R, Ikezono K, Zerkowski HR, Reidemeister JC. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science 1986;231:1584-1585.
17. Bristow MR, Larrabee P, Muller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin Investig 1992;70:S105-113.
18. Jones CR, Hamilton CA, Deighton N, Reid JL. Cardiac and lymphocyte beta-adrenoceptors in perinephritis hypertension in the rabbit. J Cardiovasc Pharmacol 1986;8:562-566.
19. Sun LS, Pantuck CB, Morelli JJ, Khambatta GH, Tierney AC, Quaegebeur JM, Smiley RM. Perioperative lymphocyte adenylyl cyclase function in the pediatric cardiac surgical patient. Crit Care Med 1996;24:1654-1659.
20. Dzimiri N, Moorji A. Relationship between alterations in lymphocyte and myocardial beta- adrenoceptor density in patients with left heart valvular disease. Clin Exp Pharmacol Physiol 1996;23:498-502.
21. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 1998;98:1783-1789.
22. Iaccarino G, Dolber PC, Lefkowitz RJ, Koch WJ. Beta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation. Hypertension 1999;33:396-401.
23. Akhter SA, Eckhart AD, Rockman HA, Shotwell K, Lefkowitz RJ, Koch WJ. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function. Circulation 1999;100:648-653.
24. Iaccarino G, Keys JR, Rapacciuolo A, Lefkowitz RJ, Rockman HA, Koch WJ. Regulation of myocardial beta ARK1 expression in catecholamine induced cardiac hypertrophy in transgenic mice overexpressing alpha 1B adrenergic receptor. J Am Coll Cardiol 2001;38:55-60.
25. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem 1997;272:17223-17229.
26. Motulsky H. Intuitive Biostatistics. New York: Oxford University Press; 1995.
27. Koch WJ, Lefkowitz RJ, Milano CA, Akhter SA, Rockman HA. Myocardial overexpression of adrenergic receptors and receptor kinases. Adv Pharmacol 1998;42:502-506.
28. Koch WJ, Lefkowitz RJ, Rockman HA. Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol 2000;62:237-260.
29. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol 1993;22:61A-71A.
30. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, Walsh RA. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-1539.
31. Small KM, Wagoner LE, Levin AM, Kardia SL, Liggett SB. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002;347:1135-1142.
32. Feldman RD, Lawton WJ, McArdle WL. Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. J Clin Invest 1987;79:290-294.
33. Gros R, Benovic JL, Tan CM, Feldman RD. G-protein-coupled receptor kinase activity is increased in hypertension (see comments). J Clin Invest 1997;99:2087-2093.
34. Werner C, Werdan K, Ponicke K, Brodde OE. Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta1-blocker treatment. Basic Res Cardiol 2001;96:290-298.
35. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-621.
36. Iaccarino G, Barbato E, Cipolleta E, Esposito A, Fiorillo A, Koch WJ, Trimarco B. Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. Hypertension 2001;38:255-260.
37. Ping P, Gelzer-Bell R, Roth DA, Kiel D, Insel PA, Hammond HK. Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart. J Clin Invest 1995;95:1271-1280.
38. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, Lefkowitz RJ, Koch WJ. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA 1997;94:12100-12105.
39. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP, Wagner TE, Vatner DE, Homcy CJ, Vatner SF. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(alphas) mouse. J Clin Invest 1999;104:551-558.
40. Cho MC, Rapacciuolo A, Koch WJ, Kobayashi Y, Jones LR, Rockman HA. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression. J Biol Chem 1999;274:22251-22256.
41. Eckhart AD, Fentzke RC, Lepore J, Lang R, Lin H, Lefkowitz RJ, Koch WJ, Leiden JM. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy. J Mol Cell Cardiol 2002;34:669-677.
42. Dorn GW II, Tepe NM, Wu G, Yatani A, Liggett SB. Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)- mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 2000;57:278-287.
43. Barbato E, Piscione F, Bartunek J, Galasso G, Cirillo P, de Luca G, Iaccarino G, de Bruyne B, Chiariello M, Wijns W. Role of beta2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 2005;111:288-294.